CCP
BMY icon

Clough Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Clough Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-376,952
Closed -$19.5M – 129
2024
Q3 		$19.5M Buy
+376,952
New +$17.7M 2% 15
2023
Q3 		– Sell
-37,700
Closed -$2.41M – 207
2023
Q2 		$2.41M Sell
37,700
-16,000
-30% -$1.07M 0.24% 107
2023
Q1 		$3.72M Buy
+53,700
New +$3.79M 0.4% 84
2019
Q1 		– Sell
-29,841
Closed -$1.55M – 133
2018
Q4 		$1.55M Sell
29,841
-112,419
-79% -$6.04M 0.18% 87
2018
Q3 		$8.83M Sell
142,260
-4,400
-3% -$261K 0.83% 42
2018
Q2 		$8.12M Buy
146,660
+13,200
+10% +$713K 0.72% 45
2018
Q1 		$8.44M Buy
133,460
+5,100
+4% +$328K 0.81% 49
2017
Q4 		$7.87M Sell
128,360
-67,600
-34% -$4.23M 0.66% 51
2017
Q3 		$12.5M Sell
195,960
-158,400
-45% -$9.25M 0.84% 41
2017
Q2 		$19.7M Sell
354,360
-34,526
-9% -$1.88M 1.37% 23
2017
Q1 		$21.1M Sell
388,886
-10,323
-3% -$566K 1.34% 20
2016
Q4 		$23.3M Buy
399,209
+195,292
+96% +$10.7M 1.55% 17
2016
Q3 		$11M Buy
203,917
+34,942
+21% +$2.24M 0.57% 58
2016
Q2 		$12.4M Buy
168,975
+3,800
+2% +$269K 0.66% 50
2016
Q1 		$10.6M Buy
165,175
+50,010
+43% +$3.15M 0.5% 64
2015
Q4 		$7.92M Sell
115,165
-135,026
-54% -$8.92M 0.37% 81
2015
Q3 		$14.8M Sell
250,191
-4,474
-2% -$284K 0.64% 55
2015
Q2 		$16.9M Sell
254,665
-56,055
-18% -$3.69M 0.65% 57
2015
Q1 		$20M Sell
310,720
-11,319
-4% -$709K 0.66% 64
2014
Q4 		$19M Sell
322,039
-102,161
-24% -$5.76M 0.68% 54
2014
Q3 		$21.7M Buy
424,200
+187,500
+79% +$9.37M 0.81% 48
2014
Q2 		$11.5M Sell
236,700
-518,200
-69% -$25.5M 0.36% 97
2014
Q1 		$39.2M Buy
+754,900
New +$40.2M 1.22% 22

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clough Capital Partners's BMY Position: Q4 2024 in Review

Clough Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 376,952 shares — an estimated $19.5M sold.

Clough Capital Partners first reported a position in BMY in Q1 2014 and held it in 23 quarters. The position peaked at $39.2M in Q1 2014. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Clough Capital Partners reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Clough Capital Partners sold 376,952 Bristol-Myers Squibb shares in Q4 2024, an estimated $19.5M.
  • Clough Capital Partners first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 23 quarters.
  • Clough Capital Partners's Bristol-Myers Squibb position peaked at $39.2M in Q1 2014.
  • 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Clough Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.